MedPath

Early Warning Model of Susceptibility and High-risk Population of Cervical Cancer Related to HPV

Conditions
Uterine Cervical Cancer
Cervical Cancer
Uterine Cervical Neoplasm
Registration Number
NCT04974424
Lead Sponsor
Huazhong University of Science and Technology
Brief Summary

Most uterine cervical high-risk human papillomavirus (HPV) infections are transient, with only a small fraction developing into cervical cancer. Family aggregation studies and heritability estimates suggest a significant inherited genetic component. Candidate gene studies and previous genome-wide association studies (GWASs) report associations between the HLA region and cervical cancer. Adopting a genome-wide approach, we aimed to establish an early warning model for a high-risk population of cervical cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
20000
Inclusion Criteria
  • (1) Case group a) Aged 25-75 years. b) Han nationality. c) Patients with cervical cancer or cervical precancerous lesions above CIN2 diagnosed by biopsy or postoperative pathological diagnosis.
  • (2) Control group: a) Aged 25-75 years. b) Han nationality. c) No family history of cervical cancer or precancerous lesions. d) The results of TCT examination showed no abnormality.
Exclusion Criteria
  • (1) suffering from other neoplastic diseases.
  • (2) pregnant women.
  • (3) those with a history of bone marrow transplantation.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Significant loci of genetic variation2

The impact of genetic variance on predisposition to cervical cancer

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Tongji Hospital

🇨🇳

Wuhan, Hubei, China

© Copyright 2025. All Rights Reserved by MedPath